
Jaar Kandidaat Begeleider Onderwerp
2005 2006 2006 2007 2007 drs J.J.Bosch drs I.Meenken, oogarts I.Homminga L.V.Ly E.J.T.van Zeeburg
Prof.dr C.Melief (LUMC) Dr G.J.van den Horn, oogarts Dr M.J.Jager (LUMC ), oogarts Dr M.J.Jager (LUMC ), oogarts
Activation of tumorspecific T cells by MHC ll uveal melanoma vaccines Onderzoek naar de klinische betekenis van oogheelkundige Immune Recovery Syndromen. Examining the role of tumor specific cytolytic T cells on tumors in an immune provileged site Studiereis University of Texas Southwestern ivm onderzoek uvea melanoom Studiejaar Harvard Medical School: Ontwikkeling tumorcelvaccin retinoblastoom
2008
drs K.Pathanapitoon
Prof dr A.Rothova (UMCU), oogarts
drs A.T.Hernowo
2009
drs L.Razzaq
Prof.dr R.J.W.de Keizer(LUMC)
Research to analyse the different aspects in diagnosis and management of iris melanoma
2009
drs D.P.Bergsma
Helmholtz instituut (UU): Dr.G.J.van der Wildt/ Dr M.A.H.L.L.Raemaekers
Predicting clinical outcome of visual detection training following cortical blindness
2009
M.I.Khan Prof.dr.F.P.M. Cremers/ Dr. A.I.den Hollander (UMCN)
The best of both worlds: Identification of novel autosomal recessive RP genes using inbred and outbred families.
2010
drs L.V.Ly
Dr M.J.Jager(LUMC), oogarts
Posterpresentatie uveamelanoom op Keystone congres te Denver 2010 2010 2010 2010 T.W.J..Chiang I.Schouten M.Carolina
S.Darma Dr M.J.Jager(LUMC), oogarts Dr M.J.Jager (LUMC), oogarts Stichting Putri Kerahiman Papua Prof. dr M.P.Mourits (AMC), oogarts
Wetenschappelijke stage aan Schepens Eye Research Institute, Harvard University. Development of a tumor cell vaccine for the treatment of retinoblastoma.
Onderzoekstage bij prof.Dick in Bristol: Inhibition of endotoxin induced uveitis by blocking complement C5. Bijdrage voor studie geneeskunde.
Eye Care Foundation
2009
Dr Pham Ngoc Dong, oogarts Vietnam
